1. Home
  2. GALT vs JMSB Comparison

GALT vs JMSB Comparison

Compare GALT & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GALT
  • JMSB
  • Stock Information
  • Founded
  • GALT 2000
  • JMSB 2005
  • Country
  • GALT United States
  • JMSB United States
  • Employees
  • GALT N/A
  • JMSB N/A
  • Industry
  • GALT Biotechnology: Pharmaceutical Preparations
  • JMSB Major Banks
  • Sector
  • GALT Health Care
  • JMSB Finance
  • Exchange
  • GALT Nasdaq
  • JMSB Nasdaq
  • Market Cap
  • GALT 232.3M
  • JMSB 270.0M
  • IPO Year
  • GALT N/A
  • JMSB N/A
  • Fundamental
  • Price
  • GALT $4.60
  • JMSB $20.17
  • Analyst Decision
  • GALT Strong Buy
  • JMSB Buy
  • Analyst Count
  • GALT 3
  • JMSB 2
  • Target Price
  • GALT $6.00
  • JMSB $22.50
  • AVG Volume (30 Days)
  • GALT 241.8K
  • JMSB 11.5K
  • Earning Date
  • GALT 08-14-2025
  • JMSB 10-22-2025
  • Dividend Yield
  • GALT N/A
  • JMSB 1.49%
  • EPS Growth
  • GALT N/A
  • JMSB 688.28
  • EPS
  • GALT N/A
  • JMSB 1.32
  • Revenue
  • GALT N/A
  • JMSB $56,750,000.00
  • Revenue This Year
  • GALT N/A
  • JMSB $18.36
  • Revenue Next Year
  • GALT N/A
  • JMSB $12.36
  • P/E Ratio
  • GALT N/A
  • JMSB $15.29
  • Revenue Growth
  • GALT N/A
  • JMSB 59.00
  • 52 Week Low
  • GALT $0.73
  • JMSB $13.81
  • 52 Week High
  • GALT $4.71
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • GALT 69.41
  • JMSB 59.19
  • Support Level
  • GALT $3.93
  • JMSB $19.19
  • Resistance Level
  • GALT $4.35
  • JMSB $20.34
  • Average True Range (ATR)
  • GALT 0.27
  • JMSB 0.45
  • MACD
  • GALT 0.03
  • JMSB 0.01
  • Stochastic Oscillator
  • GALT 91.67
  • JMSB 80.28

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: